Alnylam Pharmaceuticals
ALNY
#440
Rank
โ‚น4.822 T
Marketcap
โ‚น36,502
Share price
1.87%
Change (1 day)
77.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company